Realta Investment Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,344
| Closed | -$229K | – | 797 |
|
|
2024
Q1 | $229K | Sell |
5,344
-346
| -6% | -$14.8K | 0.05% | 376 |
|
|
2023
Q4 | $211K | Sell |
5,690
-2,098
| -27% | -$77.7K | 0.05% | 402 |
|
|
2023
Q3 | $278K | Hold |
7,788
| – | – | 0.06% | 310 |
|
|
2023
Q2 | $278K | Sell |
7,788
-931
| -11% | -$33.2K | 0.06% | 318 |
|
|
2023
Q1 | $310K | Sell |
8,719
-1,971
| -18% | -$70.1K | 0.08% | 283 |
|
|
2022
Q4 | $376K | Buy |
10,690
+462
| +5% | +$16.2K | 0.09% | 253 |
|
|
2022
Q3 | $301K | Sell |
10,228
-1,650
| -14% | -$48.6K | 0.08% | 280 |
|
|
2022
Q2 | $650K | Buy |
11,878
+201
| +2% | +$11K | 0.16% | 150 |
|
|
2022
Q1 | $636K | Buy |
11,677
+1,961
| +20% | +$107K | 0.13% | 180 |
|
|
2021
Q4 | $536K | Buy |
9,716
+3,151
| +48% | +$174K | 0.12% | 202 |
|
|
2021
Q3 | $314K | Sell |
6,565
-232
| -3% | -$11.1K | 0.07% | 287 |
|
|
2021
Q2 | $338K | Sell |
6,797
-681
| -9% | -$33.9K | 0.08% | 265 |
|
|
2021
Q1 | $334K | Sell |
7,478
-140
| -2% | -$6.25K | 0.09% | 259 |
|
|
2020
Q4 | $350K | Sell |
7,618
-1,708
| -18% | -$78.5K | 0.1% | 221 |
|
|
2020
Q3 | $439K | Sell |
9,326
-1,416
| -13% | -$66.7K | 0.15% | 170 |
|
|
2020
Q2 | $548K | Sell |
10,742
-1,168
| -10% | -$59.6K | 0.18% | 144 |
|
|
2020
Q1 | $564K | Sell |
11,910
-1,562
| -12% | -$74K | 0.24% | 114 |
|
|
2019
Q4 | $775K | Buy |
13,472
+1,175
| +10% | +$67.6K | 0.21% | 110 |
|
|
2019
Q3 | $655K | Sell |
12,297
-308
| -2% | -$16.4K | 0.18% | 129 |
|
|
2019
Q2 | $630K | Buy |
12,605
+729
| +6% | +$36.4K | 0.17% | 144 |
|
|
2019
Q1 | $613K | Buy |
+11,876
| New | +$613K | 0.28% | 111 |
|